Key Statistics
Market Cap$7.54B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$0.38
52W High$12.43
52W Low$1.83
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees691
Price Performance
1 Week-1.08%
3 Month+250.96%
1 Year+145.79%
FinancialsAnnual · QuiverQuant
Revenue$622,000
Assets$504.45M
Liabilities$1.09B
Net Income$583.85M loss
About
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze IBRX with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.
